These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 33972122)
1. Systemic thrombolysis in a patient with massive acute valvular thrombosis. Juárez-Najarro S; Solis-Jimenez F; Jimenez-Ruan LA; Salazar-Delgado O; Araiza-Garaygordobil D Am J Emerg Med; 2021 Nov; 49():439.e1-439.e2. PubMed ID: 33972122 [TBL] [Abstract][Full Text] [Related]
2. Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ratio levels. Farzaneh K; Mortazavi SH; Oraii A; Abbasi K; Salehi Omran A; Ahmadi Tafti SH; Bozorgi A; Kazemi Saeed A; Salarifar M; Sadeghian S J Card Surg; 2020 Oct; 35(10):2522-2528. PubMed ID: 33043663 [TBL] [Abstract][Full Text] [Related]
3. Thrombolysis of an acute prosthetic mitral valve thrombosis presented with cardiogenic shock under the guidance of continuous transoesophageal monitoring. Biteker M; Duran NE; Gündüz S; Gökdeniz T; Kaya H; Aykan AC; Ozkan M Eur J Echocardiogr; 2009 May; 10(3):468-70. PubMed ID: 19252185 [TBL] [Abstract][Full Text] [Related]
4. Thrombolysis for Left-Sided Prosthetic Valve Thrombosis: Short- and Long-Term Outcomes. Gupta S J Heart Valve Dis; 2016 Mar; 25(2):214-220. PubMed ID: 27989070 [TBL] [Abstract][Full Text] [Related]
5. Subacute aortic prosthetic mechanical valve thrombosis complicated with acute coronary syndrome. Kanar BG; Tigen K; Atas H; Cincin A; Ozben B Am J Emerg Med; 2018 Oct; 36(10):1924.e1-1924.e3. PubMed ID: 30017689 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial. Özkan M; Kalçık M; Gürsoy MO; Öcal L; Griffini S; Karakoyun S; Yesin M; Gündüz S; Astarcıoğlu MA; Bayam E; Cerşit S; Aykan AÇ; Cugno M J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322 [TBL] [Abstract][Full Text] [Related]
7. Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients. Cáceres-Lóriga FM; Pérez-López H; Morlans-Hernández K; Facundo-Sánchez H; Santos-Gracia J; Valiente-Mustelier J; Rodiles-Aldana F; Marrero-Mirayaga MA; Betancourt BY; López-Saura P J Thromb Thrombolysis; 2006 Apr; 21(2):185-90. PubMed ID: 16622616 [TBL] [Abstract][Full Text] [Related]
8. Thrombolytic therapy in prosthetic valve thrombosis during early pregnancy. Srinivas BC; Moorthy N; Kuldeep A; Jeevan H; Chandrasekaran D; Manjunath CN Indian Heart J; 2012; 64(1):74-6. PubMed ID: 22572429 [TBL] [Abstract][Full Text] [Related]
9. The leading role of thrombolysis in the management of prosthetic valve thrombosis. Gürsoy MO; Kalçık M; Yesin M; Karakoyun S; Özkan M Indian Heart J; 2016; 68(2):205-6. PubMed ID: 27133340 [No Abstract] [Full Text] [Related]
10. Thrombolysis may be a universal therapeutic option in left-sided prosthetic valve thrombosis. Caceres-Loriga FM Indian Heart J; 2018; 70(6):949-950. PubMed ID: 30580874 [No Abstract] [Full Text] [Related]
11. Thrombolytic therapy for prosthetic valve thrombosis in Third World countries. Agrawal D; Dubey S; Saket B; Bhargava M; Mehta N; Lohchab SS; Satsangi DK; Nigam M; Gupta BK; Khanna SK Indian Heart J; 1997; 49(4):383-6. PubMed ID: 9358660 [TBL] [Abstract][Full Text] [Related]
12. Use of tenecteplase in recurrent prosthetic valve thrombosis. Hariram V; Sharma NP J Heart Valve Dis; 2013 Nov; 22(6):872-3. PubMed ID: 24597413 [TBL] [Abstract][Full Text] [Related]
13. Thrombolytic treatment of prosthetic valve thrombosis: a study using Urokinase. Huang F; Lan Y; Cheng Z; Zhang Z; Ren F J Cardiothorac Surg; 2020 Oct; 15(1):286. PubMed ID: 33004057 [TBL] [Abstract][Full Text] [Related]
14. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. Lengyel M; Vegh G; Vandor L J Heart Valve Dis; 1999 Mar; 8(2):167-73. PubMed ID: 10224577 [TBL] [Abstract][Full Text] [Related]